Dr.Evidence is the leading pharma labeling and regulatory landscape intelligence platform. With more than two decades of domain expertise in life sciences, our platform helps our clients get their products to market and keep them there. Dr.Evidence delivers the industry's most expansive content—from drug labels to regulatory packages, clinical trials and more—with streamlined workflows and automated monitoring that accelerates time-to-market. It also features a library of more than 25 proprietary, fit-for-purpose AI models, driving dramatic efficiencies.
Dr.Evidence was founded in 2004. In 2026, Dr.Evidence was acquired by Ethos Software.
Whether you’re tracking label changes, preparing submissions, or analyzing competitive prior precedent, Dr.Evidence helps you move faster with confidence. Reach out, and our team will follow up to understand your needs and show you what’s possible.
